CD Biosynsis offers specialized Synechococcus spp. CRISPR Interference (CRISPRi) services, providing a high-efficiency, non-mutagenic platform for the tunable and reversible knockdown of gene expression. In cyanobacteria like Synechococcus elongatus PCC 7942 and Synechococcus sp. PCC 7002, many central metabolic pathways and photosynthetic components are essential for survival. Our CRISPRi platform utilizes a catalytically inactive "dead" Cas9 (dCas9) or dCas12a to sterically block transcription without introducing permanent double-strand breaks. This allows researchers to suppress essential genes and systematically explore the metabolic network without the lethality of a traditional knockout.
Our CRISPRi solutions for Synechococcus are specifically engineered to navigate the unique genetic landscape of cyanobacteria, including their polyploid nature and high transcriptional rates. We utilize codon-optimized dCas variants and high-efficiency guide RNA (gRNA) design tailored to the transcription start sites (TSS) and promoter regions of the cyanobacterial genome. This service is essential for researchers looking to redirect carbon flux away from primary products like glycogen toward high-value molecules—such as 2,3-butanediol, squalene, or sucrose—while maintaining the overall fitness and photosynthetic integrity of the algal culture.
Get a QuoteCRISPRi functions by targeting a dCas-gRNA complex to a specific DNA sequence, typically within the promoter or the 5' untranslated region (UTR). In Synechococcus, the complex acts as a physical barrier to RNA polymerase, effectively silencing the gene at the transcriptional level. Unlike standard CRISPR-Cas9, which requires time-consuming chromosomal segregation in polyploid cyanobacteria, CRISPRi can achieve immediate phenotypic changes by repressing expression across all genome copies simultaneously.
Our platform is meticulously optimized for the cyanobacterial intracellular environment. We provide both constitutive and inducible systems, allowing for temporal control over gene silencing. For example, researchers can grow a healthy culture to a high density before inducing the repression of competitive pathways, thereby maximizing bioproduct yield. By bypassing the limitations of antisense RNA (asRNA) or sRNA-based silencing—which are often inconsistent—our CRISPRi services offer a highly specific, robust, and predictable tool for synthetic biology in Synechococcus.
We provide a variety of CRISPRi configurations designed to meet the specific functional requirements of basic research and industrial strain development.
Chemical Inducers
Utilizing tightly regulated promoters (e.g., L-rhamnose, IPTG, or Vanillic acid inducible) to trigger repression at specific growth phases.
Reversibility
Enabling the study of temporal gene functions by simply removing the inducer, allowing gene expression to return to native levels.
Multi-Gene Repression
Simultaneously targeting multiple competitive enzymes (e.g., those involved in glycogen and polyhydroxyalkanoate synthesis) to maximize carbon redirection.
gRNA Arrays
Utilizing synthetic gRNA arrays to ensure balanced and efficient silencing across different metabolic nodes within a single biosynthetic pathway.
Lower Toxicity
dCas12a is often better tolerated in cyanobacteria than dCas9, allowing for higher expression levels and deeper silencing without affecting growth.
Simplified Multiplexing
Taking advantage of dCas12a's inherent RNA-processing ability to target multiple sites using a single short CRISPR array transcript.
Our rigorous workflow ensures the precise delivery of engineered strains with quantitative verification of mRNA reduction.
1. Computational Target Selection
2. Cassette Assembly & Prep
3. Transformation & Monoclonal Isolation
4. Quantitative Validation
Bioinformatic mapping of the target Transcription Start Site (TSS). Design of multiple gRNAs per gene to identify the most effective repression site (typically within the -50 to +100 bp window relative to the TSS).
Construction of CRISPRi vectors (integrative or replicative) featuring codon-optimized dCas proteins. Integration of cyanobacterial-specific promoters and selection markers.
qPCR Validation: Measurement of target gene mRNA levels to confirm the percentage of knockdown. Phenotypic Characterization: Evaluation of growth stability and bioproduct titers. Delivery of cryopreserved strains.
No Segregation Required
Unlike knockouts, CRISPRi functions immediately across all chromosomal copies, bypassing the need for lengthy segregation cycles in polyploid hosts.
Essential Gene Access
Enables the study and manipulation of vital metabolic nodes that cannot be deleted, such as those in the Calvin cycle or photosynthesis.
Tunable & Reversible
Adjust repression levels via gRNA placement or inducer concentration. The knockdown is reversible, offering high flexibility for research.
Multiplexing Efficiency
Ideal for complex metabolic engineering where multiple competitive genes must be downregulated simultaneously to optimize carbon flux.
1. Why use CRISPRi instead of traditional RNAi in cyanobacteria?
Cyanobacteria often lack the complex RNAi machinery (Dicer/RISC) found in eukaryotes. CRISPRi targets DNA directly, making it far more robust and predictable for gene silencing in Synechococcus.
2. Can CRISPRi completely silence a gene?
While CRISPRi typically achieves 60% to 95% reduction in transcript levels, it is rarely a "zero" expression. This partial knockdown is often an advantage when working with essential genes.
3. How do you handle the polyploidy of Synechococcus PCC 7942?
Because dCas proteins act as a physical block, they will bind to all available genomic copies as long as the protein and gRNA are expressed. This provides a unified phenotype across all chromosomes.
4. Is dCas9 toxic to cyanobacterial cells?
Constitutive high expression can be stressful. We mitigate this by using inducible promoters or by utilizing dCas12a, which generally exhibits lower toxicity in photosynthetic hosts.
5. What validation data do you provide?
We provide RT-qPCR data comparing mRNA levels between the wild-type and the CRISPRi strain to quantify the efficiency of the knockdown.
6. Can you target multiple genes simultaneously?
Yes, we can design multiplexed arrays to repress multiple genes in a single transformation, perfect for metabolic pathway optimization.
7. Is the CRISPRi system integrated into the genome or on a plasmid?
We offer both options. Integrative systems at Neutral Sites offer higher stability, while replicative plasmids allow for easier removal (curing) of the system.
8. What is the typical turnaround time for a CRISPRi project?
A standard project from computational design to the delivery of verified monoclonal strains typically takes 10 to 14 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.